Millennium Management’s iBio IBIO Stock Holding History

Millennium Management’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.89M	Buy	1,651,473 +101,623	+7%	+$182K	﹤0.01%	3511
2026 Q1	$2.94M	Buy	+1,549,850	New	+$3.6M	﹤0.01%	3484
2023 Q1	–	Sell	-3,535	Closed	-$31K	–	6578
2022 Q4	$31K	Sell	3,535 -1,323	-27%	-$44.8K	﹤0.01%	5924
2022 Q3	$414K	Sell	4,858 -4,373	-47%	-$602K	﹤0.01%	5121
2022 Q2	$1.22M	Buy	+9,231	New	+$1.39M	﹤0.01%	4199
2022 Q1	–	Sell	-192	Closed	-$53K	–	7146
2021 Q4	$53K	Buy	+192	New	+$73.2K	﹤0.01%	6462
2021 Q3	–	Sell	-38	Closed	-$29K	–	6989
2021 Q2	$29K	Sell	38 -329	-90%	-$240K	﹤0.01%	6415
2021 Q1	$282K	Buy	367 +105	+40%	+$91.5K	﹤0.01%	5253
2020 Q4	$137K	Sell	262 -263	-50%	-$214K	﹤0.01%	4963
2020 Q3	$533K	Buy	525 +279	+113%	+$404K	﹤0.01%	3542
2020 Q2	$273K	Buy	246 +72	+41%	+$47.1K	﹤0.01%	3710
2020 Q1	$92K	Buy	+174	New	+$67K	﹤0.01%	3564
2016 Q3	–	Sell	-2	Closed	-$7K	–	3405
2016 Q2	$7K	Sell	2 -9	-82%	-$29.4K	﹤0.01%	3120
2016 Q1	$31K	Buy	+11	New	+$31.5K	﹤0.01%	3175
2014 Q4	–	Sell	-3	Closed	-$9K	–	4074
2014 Q3	$9K	Buy	+3	New	+$7.32K	﹤0.01%	3639

Other funds holding IBIO

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Millennium Management's IBIO Position: Q2 2026 in Review

Millennium Management increased its iBio (IBIO) stake by 6.6% in Q2 2026, buying an estimated $182K and bringing the position to 1,651,473 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #3511.

Millennium Management first reported a position in IBIO in Q3 2014 and has held it in 15 quarters since. The position peaked at $2.94M in Q1 2026. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

Millennium Management held 1,651,473 shares of iBio worth $2.89M as of Q2 2026.
Millennium Management bought 101,623 iBio shares in Q2 2026, an estimated $182K.
iBio made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #3511 holding.
Millennium Management first reported a position in iBio in Q3 2014 and has held it in 15 quarters since.
Millennium Management's iBio position peaked at $2.94M in Q1 2026.
55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.